Your browser doesn't support javascript.
loading
Mass spectrometry-based multi-attribute method in protein therapeutics product quality monitoring and quality control.
Yang, Feng; Zhang, Jennifer; Buettner, Alexander; Vosika, Eva; Sadek, Monica; Hao, Zhiqi; Reusch, Dietmar; Koenig, Maximiliane; Chan, Wayman; Bathke, Anja; Pallat, Hilary; Lundin, Victor; Kepert, Jochen Felix; Bulau, Patrick; Deperalta, Galahad; Yu, Christopher; Beardsley, Richard; Camilli, Tura; Harris, Reed; Stults, John.
Afiliação
  • Yang F; Pharma Technical Development, Genentech, A member of the Roche Group, South San Francisco, CA, USA.
  • Zhang J; Pharma Technical Development, Genentech, A member of the Roche Group, South San Francisco, CA, USA.
  • Buettner A; Pharma Technical Development Analytics, Roche Diagnostics GmbH, Penzberg, Germany.
  • Vosika E; Pharma Technical Development Analytics, Roche Diagnostics GmbH, Penzberg, Germany.
  • Sadek M; Pharma Technical Development, Genentech, A member of the Roche Group, South San Francisco, CA, USA.
  • Hao Z; Pharma Technical Development, Genentech, A member of the Roche Group, South San Francisco, CA, USA.
  • Reusch D; Pharma Technical Development Analytics, Roche Diagnostics GmbH, Penzberg, Germany.
  • Koenig M; Large Molecule Research, Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany.
  • Chan W; Pharma Technical Development, Genentech, A member of the Roche Group, South San Francisco, CA, USA.
  • Bathke A; Pharma Technical Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Pallat H; Pharma Quality & Compliance-Analytical Science, Genentech, A member of the Roche Group, South San Francisco, CA, USA.
  • Lundin V; Pharma Technical Development, Genentech, A member of the Roche Group, South San Francisco, CA, USA.
  • Kepert JF; Pharma Technical Development Analytics, Roche Diagnostics GmbH, Penzberg, Germany.
  • Bulau P; Pharma Technical Development, F. Hoffmann-La Roche Ltd, Basel, Switzerland.
  • Deperalta G; Pharma Technical Development, Genentech, A member of the Roche Group, South San Francisco, CA, USA.
  • Yu C; Pharma Technical Development, Genentech, A member of the Roche Group, South San Francisco, CA, USA.
  • Beardsley R; Pharma Technical Development, Genentech, A member of the Roche Group, South San Francisco, CA, USA.
  • Camilli T; Pharma Technical Regulatory, Genentech, A Member of the Roche Group, South San Francisco, CA, USA.
  • Harris R; Pharma Technical Development, Genentech, A member of the Roche Group, South San Francisco, CA, USA.
  • Stults J; Pharma Technical Development, Genentech, A member of the Roche Group, South San Francisco, CA, USA.
MAbs ; 15(1): 2197668, 2023.
Article em En | MEDLINE | ID: mdl-37057828
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Anticorpos Monoclonais Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Produtos Biológicos / Anticorpos Monoclonais Idioma: En Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos